EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-21.28%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$380M
AUM Growth
+$380M
(-23%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
66.51%
Holding
81
New
10
Increased
16
Reduced
22
Closed
22
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$37.5M |
| 2 |
TG Therapeutics
TGTX
|
$16.6M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$15.8M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$11.7M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$10.4M |
Top Sells
| 1 |
GSK
GSK
|
$19.9M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$18.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$16M |
| 4 |
The Ensign Group
ENSG
|
$12M |
| 5 |
Sanofi
SNY
|
$11M |
Sector Composition
| 1 | Healthcare | 89.32% |
| 2 | Communication Services | 2.19% |
| 3 | Financials | 0.12% |
| 4 | Industrials | 0% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
26
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.16M | 0.54% |
+524,257
| New | +$2.16M |
|
27
Cytokinetics
CYTK
$5.98B
| $2.14M | 0.53% |
181,700
| – | – |
|
28
Community Health Systems
CYH
$392M
| $1.94M | 0.48% |
580,350
-14
| -0% | -$47 |
|
29
Envista
NVST
$3.37B
| $1.63M | 0.41% |
109,212
-397,466
| -78% | -$5.94M |
|
|
OXFD
30
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.59M | 0.4% |
172,193
-177,630
| -51% | -$1.64M |
|
|
AGRX
31
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.32M | 0.33% |
711,756
-424,250
| -37% | -$788K |
|
|
MYOK
32
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.3M | 0.32% |
27,752
+6,300
| +29% | +$295K |
|
|
ALBO
33
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $1.28M | 0.32% |
78,029
| – | – |
|
|
AUTL
34
Autolus Therapeutics
AUTL
$383M
| $1.26M | 0.31% |
+210,013
| New | +$1.26M |
|
35
Immunovant
IMVT
$2.91B
| $1.2M | 0.3% |
76,866
| – | – |
|
36
Liquidia Corp
LQDA
$2.52B
| $1.15M | 0.29% |
244,637
-39,466
| -14% | -$186K |
|
|
HSKA
37
DELISTED
Heska Corp
HSKA
| $1.15M | 0.29% |
20,771
| – | – |
|
|
OTIC
38
DELISTED
Otonomy, Inc.
OTIC
| $1.11M | 0.28% |
561,737
+11,072
| +2% | +$21.8K |
|
|
DRNA
39
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.1M | 0.27% |
59,774
+41,100
| +220% | +$755K |
|
|
TLGT
40
DELISTED
Teligent, Inc
TLGT
| $1.08M | 0.27% |
3,862,903
-638,896
| -14% | -$179K |
|
41
scPharmaceuticals
SCPH
$296M
| $980K | 0.24% |
132,419
-169,217
| -56% | -$1.25M |
|
42
Cyclerion Therapeutics
CYCN
$7.75M
| $893K | 0.22% |
+337,145
| New | +$893K |
|
|
AFMD
43
DELISTED
Affimed
AFMD
| $886K | 0.22% |
560,800
-296,971
| -35% | -$469K |
|
44
Xenon Pharmaceuticals
XENE
$2.99B
| $812K | 0.2% |
71,591
-144,018
| -67% | -$1.63M |
|
45
Protara Therapeutics
TARA
$125M
| $747K | 0.19% |
+32,478
| New | +$747K |
|
46
InflaRx
IFRX
$117M
| $747K | 0.19% |
195,488
-139,130
| -42% | -$531K |
|
47
Carisma Therapeutics
CARM
$15.5M
| $729K | 0.18% |
1,300,000
| – | – |
|
48
Aquestive Therapeutics
AQST
$478M
| $657K | 0.16% |
300,000
-50,000
| -14% | -$110K |
|
|
IGMS
49
DELISTED
IGM Biosciences
IGMS
| $549K | 0.14% |
9,770
-54,830
| -85% | -$3.08M |
|
50
MacroGenics
MGNX
$121M
| $535K | 0.13% |
91,998
-25,000
| -21% | -$146K |
|